# Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

> **NCT01172691** · PHASE2 · COMPLETED · sponsor: **Baylor Research Institute** · enrollment: 23 (actual)

## Conditions studied

- Liver Transplant

## Interventions

- **DRUG:** Inhaled Nitric Oxide (iNO)
- **DRUG:** Placebo Arm (Nitrogen)

## Key facts

- **NCT ID:** NCT01172691
- **Lead sponsor:** Baylor Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-01-22
- **Final completion:** 2014-01-22
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172691, "Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01172691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*